According to Biohealth Investor GENZ has restarted production of Fabrazyme and Cerezyme at the Allston plant. Will they be allowed to sell that production when they eventually satisfy the FDA?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.